S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q1 2023

Deep Track Capital

Period: Q1 2023 Β· Filed: 2023-05-15
View on SEC EDGAR β†—
AUM
$2.43B
Total portfolio value
Positions
58
Reported securities
Top Holding
JAZZ
7.2% $175.6M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
JAZZJAZZ PHARMACEUTICALS PLC$175.6M7.21%$146.33$243.47+66.4%
7.2%
ISEEIVERIC BIO INC$158.2M6.50%β€”β€”
6.5%
TVTXTRAVERE THERAPEUTICS INC$138.3M5.68%$22.49$56.92+153.1%
5.7%
IMVTIMMUNOVANT INC$115.3M4.73%$15.51$38.79+150.1%
4.7%
INSMINSMED INC$110.8M4.55%$17.05$111.60+554.5%
4.5%
IONSIONIS PHARMACEUTICALS INC$101.3M4.16%$35.74$81.80+128.9%
4.2%
ITCIINTRA-CELLULAR THERAPIES INC$92.1M3.78%β€”β€”
3.8%
PLRXPLIANT THERAPEUTICS INC$91.0M3.74%$26.60$1.17-95.6%
3.7%
ALKSALKERMES PLC$84.6M3.47%$28.19$54.58+93.6%
3.5%
SWTXSPRINGWORKS THERAPEUTICS INC$79.8M3.28%β€”β€”
3.3%
KDNYCHINOOK THERAPEUTICS INC$69.5M2.85%β€”β€”
2.9%
RETAREATA PHARMACEUTICALS INC$66.3M2.72%β€”β€”
2.7%
VRNAVERONA PHARMA PLC$64.0M2.63%β€”β€”
2.6%
GPCRSTRUCTURE THERAPEUTICS INC$63.0M2.59%$23.79$53.45+124.7%
2.6%
DVAXDYNAVAX TECHNOLOGIES CORP$62.3M2.56%β€”β€”
2.6%
BCYCBICYCLE THERAPEUTICS PLC$60.0M2.46%$21.27$4.35-79.5%
2.5%
GERNGERON CORP$58.3M2.39%$2.17$1.36-37.3%
2.4%
BIIBBIOGEN INC$55.6M2.28%$278.03$216.12-22.3%
2.3%
DICEDICE THERAPEUTICS INC$45.8M1.88%β€”β€”
1.9%
AGENAGENUS INC$45.6M1.87%$29.83$3.49-88.3%
1.9%
SGENPUTSEAGEN INC$44.1M1.81%β€”β€”
1.8%
PACBPACIFIC BIOSCIENCES CALIF IN$40.6M1.67%$11.58$1.68-85.5%
1.7%
FDMT4D MOLECULAR THERAPEUTICS IN$39.2M1.61%$17.19$13.00-24.4%
1.6%
BEAMBEAM THERAPEUTICS INC$38.3M1.57%$30.62$34.79+13.6%
1.6%
EXELEXELIXIS INC$37.5M1.54%$19.41$55.85+187.7%
1.5%
ARGXPUTARGENX SE$37.3M1.53%$372.58$939.68+152.2%
1.5%
VRDNVIRIDIAN THERAPEUTICS INC$31.3M1.29%$25.44$19.40-23.7%
1.3%
AUTLAUTOLUS THERAPEUTICS PLC$27.6M1.13%$1.84$1.58-14.1%
1.1%
ETNB89BIO INC$27.4M1.13%β€”β€”
1.1%
DYNDYNE THERAPEUTICS INC$26.9M1.10%$11.52$23.07+100.3%
1.1%

Quarter-on-Quarter Activity

Q1 2023 vs. Q4 2022

New Positions (8)

TickerIssuerNotionalSince Filing
ITCIINTRA-CELLULAR THERAPIES INC$92.1M
ALKSALKERMES PLC$84.6M+93.6%
GPCRSTRUCTURE THERAPEUTICS INC$63.0M+124.7%
SGENPUTSEAGEN INC$44.1M
PACBPACIFIC BIOSCIENCES CALIF IN$40.6M-85.5%
EXELEXELIXIS INC$37.5M+187.7%
ARGXPUTARGENX SE$37.3M+152.2%
DCPHDECIPHERA PHARMACEUTICALS IN$21.1M

Exited Positions (8)

TickerIssuerNotional
ASNDASCENDIS PHARMA A/S$85.5M
SRPTSAREPTA THERAPEUTICS INC$68.5M
HZNPHORIZON THERAPEUTICS PUB L$56.9M
HZNPHORIZON THERAPEUTICS PUB L$56.9M
ALBOALBIREO PHARMA INC$36.8M
ASNDASCENDIS PHARMA A/S$30.4M
ESPRESPERION THERAPEUTICS INC NE$24.9M
BMRNBIOMARIN PHARMACEUTICAL INC$19.6M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
RETAREATA PHARMACEUTICALS INC$65.8M+5685.7%
GERNGERON CORP$40.4M+262.4%-37.3%
DVAXDYNAVAX TECHNOLOGIES CORP$37.5M+172.8%
IONSIONIS PHARMACEUTICALS INC$55.8M+135.0%+128.9%
PLRXPLIANT THERAPEUTICS INC$57.5M+97.5%-95.6%
INSMINSMED INC$25.6M+52.4%+554.5%
IPSCCENTURY THERAPEUTICS INC$-0.0M+47.0%
JAZZJAZZ PHARMACEUTICALS PLC$36.4M+37.4%+66.4%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ETNBPUT89BIO INC$-48.9M-99.9%
RAPTRAPT THERAPEUTICS INC$-15.4M-56.2%
ETNBPUT89BIO INC$-21.6M-53.2%
HRTXHERON THERAPEUTICS INC$-11.4M-50.2%
BIIBBIOGEN INC$-27.5M-33.3%-22.3%
VRDNVIRIDIAN THERAPEUTICS INC$-20.4M-30.5%-23.7%
ALLKALLAKOS INC$-25.3M-26.8%
IMVTIMMUNOVANT INC$-57.1M-23.5%+150.1%
← Back to Hedge Funds
Deep Track Capital Q1 2023 13F Filing β€” Holdings & Portfolio | MarketsFN